Publication | Closed Access

Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia–reperfusion in rats

NanomedicineNanotherapeuticsOx26 AntibodyBiochemistryAmino AcidsMedicineDrug Delivery SystemsVascular BiologyNeuroprotectionNeurologyCerebral Ischemia–reperfusionCerebral Blood FlowReperfusion InjuryPharmacologyIschemic SyndromeCerebral Vascular Regulation